Axsome Therapeutics, Inc. · NASDAQ:AXSM
Tabuteau Herriot sold 49,670 Axsome Therapeutics, Inc. shares (Form 4)
Traded Jun 9, 2026 · Filed Jun 9, 2026
On Jun 9, 2026, Tabuteau Herriot (Director, Chief Executive Officer, 10% owner) sold 49,670 Axsome Therapeutics, Inc. shares at US$241.01 for US$12M under a trading plan, leaving 7,229 shares. Filed Jun 9, 2026 (Form 4).
- Sold
- 49,670 shares
- Price
- US$241.01
- Value
- US$12M
- Holding after
- 7,229 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | Option exercise | 49,670 | US$4.95 | 56,899 | Direct |
| Jun 9, 2026 | Common Stock | Sale | 49,670 | US$241.01 | 7,229 | Direct |
Source
Related
- Axsome Therapeutics, Inc.
- Tabuteau Herriot
- Axsome Therapeutics, Inc. shareholders
- Form 4 · Tabuteau Herriot · Aug 7, 2026
- Form 4 · Tabuteau Herriot · Jul 1, 2026
- Form 4 · Jacobson Mark L. · Sep 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Jeffs Roger · Jun 11, 2026
- Form 4 · Mahony Susan · Jun 10, 2026
- Form 4 · Coleman Mark · Jun 10, 2026